Notification and current-status evidence
The sent-report ledger records the first outgoing report at . A report was sent to the recorded registrar; contact details remain in Domain Intelligence. The latest stored availability evidence still shows the domain reachable; 5 months has elapsed since the first outgoing report.
ICANN RAA §3.18 describes registrar abuse-contact and handling obligations. This section records outgoing timestamps and later availability. It does not by itself prove receipt, acknowledgement, investigation, remediation, or contractual non-compliance.
purepharmas[.]com
“Research-Grade Peptides”
Ringkasan bukti
The domain purepharmas.com was registered on March 11, 2026 and is hosted on IP 193.23.118.89, which belongs to ASN AS214036 (Ultahost, Inc.) and resolves to the Netherlands. The authoritative nameservers are elliott.ns.cloudflare.com and may.ns.cloudflare.com, and the site presents a valid Let’s Encrypt R13 TLS certificate. The landing page returns HTTP 200 and carries the title “Research-Grade Peptides,” suggesting a fabricated pharmaceutical front.
Infrastructure analysis shows a WordPress stack backed by MySQL, PHP, Yoast SEO, Apache HTTP Server, Underscore.js, Swiper, and reCAPTCHA. An MX record for mail.purepharmas.com is present with priority 0, indicating a functional mail subsystem. The domain’s Gridinsoft trust score is 0 / 100, and VirusTotal reports a single vendor detection out of 95 scanners. The domain appears on one external blocklist and is already listed by PhishDestroy as malicious.
Threat assessment identifies a high‑risk brand‑impersonation campaign targeting the “compound” brand, with the profile labeled as a cryptocurrency scam. The site’s content and language are crafted to lure victims into purchasing purported research‑grade peptides, likely to harvest cryptocurrency payments. While the exact payment mechanisms are not visible in the current snapshot, the presence of reCAPTCHA and a legitimate TLS certificate suggests an attempt to appear trustworthy and evade automated detection.
Defenders should immediately block purepharmas.com at DNS and proxy layers, enforce email filtering for the associated MX host, and monitor for any outbound connections to the 193.23.118.89 address. Continuous scanning of related Cloudflare‑served subdomains is advised, as is the deployment of sinkhole redirects for any future resolution attempts. Given the active status and high risk rating, organizations should also alert users about the fraudulent “Research‑Grade Peptides” offering and reinforce policies against unsolicited cryptocurrency payment requests.
Snapshot bukti yang dikirim
- Dikirim
- Catatan buku besar
- 1
- ID kasus
PD-20260311-F97AB5- Judul halaman yang direkam
- Research-Grade Peptides & High-Purity Research Compounds
- Artefak PDF
- Bukti PDF
Dasar hukum
Teks bukti lengkap
Illegal Activities: Active phishing operation targeting victims
Fraud & Deception: Impersonation of legitimate services
Identity Theft: Collection of credentials under false pretenses
Applicable Laws (IS):
International Anti-Cybercrime Regulations
Budapest Convention on Cybercrime
Universal Fraud Prevention Laws
Phishing activities violate international cybercrime conventions and IS's domestic fraud laws.
Action Required: This evidence-backed report demonstrates clear violations requiring suspension per your policies. Continued hosting exposes your organization to regulatory scrutiny and potential legal liability.
Data Coverage
Intelijen Keamanan Jaringan
| Detection System | Indicator | Verdict | Alert |
|---|---|---|---|
| DNS4EU | purepharmas.com |
malicious | Sinkholed |
Alur Tanggapan Ancaman Pipeline
Cakupan daftar blokir
10 sumber eksternal dipantau · snapshot tersimpan 11/08/2026
Linimasa deteksi
-
VirusTotal
0 → 1
Tangkapan tersimpan
Intelijen Domain
Detail teknisDNS, nama TLS, dan stempel waktu
ICANN OVERSIGHT
Akreditasi dan konteks RAA
Akreditasi dan konteks RAA
Registrar accreditation and DNS abuse obligations
For this gTLD, the registrar above operates under an ICANN accreditation agreement. The links below provide the official fee schedule and current DNS abuse compliance guidance.
Accreditation is a contract, not a safety certification.
RAA §3.18 establishes abuse-contact and handling requirements. This report can document stored outbound notices and later technical observations; it does not by itself establish receipt, investigation, remediation, or contractual non-compliance.
Analisis VirusTotal
Analisis Performa Situs
Google PageSpeed Insights — mobile performance audit of purepharmas.com · checked Mar 11, 2026
Apakah Anda Terpengaruh oleh Situs Ini?
Jika Anda memasukkan kredensial akun, informasi pribadi atau pembayaran, atau mengunduh file dari domain ini, segera ambil tindakan. Di bawah ini adalah sumber daya untuk membantu Anda melaporkan insiden tersebut dan melindungi diri Anda sendiri.
Laporkan kepada Pihak Berwenang di Daerah Anda
Pilih negara Anda untuk mendapatkan kontak resmi kejahatan dunia maya, atau membuat draf pengaduan →.
Periksa Domain Apa Pun
Analisis ancaman menggunakan daftar blokir yang disimpan, WHOIS, DNS, dan bukti pemindaian publik
Pindai SekarangLaporkan Phishing
Laporkan domain yang mencurigakan ke basis data ancaman kami — lindungi komunitas
LaporanPemberitahuan Ancaman Real-Time
Laporan phishing terbaru dan perubahan ketersediaan yang diamati
PantauTetap Terinformasi, Tetap Aman
Pantau ancaman secara langsung atau ajukan keberatan terhadap daftar ini jika Anda yakin ini merupakan false positive